05:39:53 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Umbral Energy Corp
Symbol UMB
Shares Issued 70,898,146
Close 2017-03-06 C$ 0.075
Market Cap C$ 5,317,361
Recent Sedar Documents

ORIGINAL: Umbral Acquires Additional 25% Interest In Phyeinmed, a Health Canada ACMPR Stage 5 Review Stage Applicant

2017-03-06 12:12 ET - News Release

(via TheNewswire)

Vancouver, B.C. / TheNewswire / March 6, 2017 - UMBRAL ENERGY CORP. (CSE: UMB)(OTC: UMBBF) (" Umbral or Company ") is pleased to announce that it has signed a binding Letter of Intent ("LOI") to acquire an additional 25% interest in PhyeinMed Inc. ("PhyeinMed"), a Health Canada Stage 5 Review Stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). With this purchase, Umbral now holds 75% ownership of PhyeinMed Inc.

Jag Bal, president and CEO states" Umbral has quickly positioned itself as the majority owner of an exceptional company in PhyeinMed. We are eager to assist PhyeinMed in their mission of becoming a licensed producer in Canada"

Currently PhyeinMed is owned 50% by Estek Ventures Corp. (Estek). This agreement will see Umbral acquire an additional 25% via its wholly owned subsidiary 1005477 BC Inc. The revised ownership of PhyeinMed will be Umbral with 75%, and Estek with 25%.

The Terms of the agreement are as follows:

  1. 1) $100,000.00 CAN cash payment

        1. a) $50,000.00 due on signing of the LOI (paid)

        2. b) $50,000.00 due on completion of Share Purchase Agreement

  1. 2) 7,000,000 shares in Umbral Energy Corp (C:UMB)

  1. 3) a. Released over 3 year escrow period.

      1. b. 100% of all shares released from escrow upon ACMPR Stage 7 license approval awarded if this is accomplished prior to the 36 months.

      2. c. 100% of all shares released from escrow as of 36 months if not released prior.

  1. 4) Estek to be granted a bonus of 1,000,000 shares of Umbral Energy Corp. (C:UMB) upon final award of ACMPR Stage 7 license approval awarded , no escrow on this award.

Pre-build preparations have started and PhyeinMed has started the preliminary work required to complete the renovations and security requirements for the 13 acre property with a 10,000 square feet steel framed building in Falkland, British Columbia. Once an affirmation letter has been received from Health Canada, PhyeinMed will be prepared for an inspection.

PhyeinMed's CEO Debra Senger and owner of Estek Ventures Corp states "I am very pleased with the recent developments, I believe we as a team, Umbral and myself, having an interest in the public company will be far more committed to the direction of the company as one cohesive unit. I look forward to our journey and I am excited for the future"

The company also plans to build through potential partnerships, international opportunities, strategic alliances, accessory and ancillary relationships with an emphasis on future revenue generating cannabis opportunities .

About Umbral Energy Corp.

The Company is currently listed as a junior resource issuer having mineral exploration projects. The Company is considering other activities to increase shareholder value, including non-resource projects.

The Company has mineral exploration projects in Utah, Nevada and Quebec. In addition the Company has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.

ON BEHALF OF THE BOARD OF DIRECTORS OF UMBRAL ENERGY CORP.

" Jag Bal"

Jagdip Bal President and CEO

NEITHER CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright (c) 2017 TheNewswire - All rights reserved.

© 2024 Canjex Publishing Ltd. All rights reserved.